<DOC>
	<DOCNO>NCT01162850</DOCNO>
	<brief_summary>Primary Objective : To determine whether improvement melasma participant take oral Polypodium Leucotomos Secondary Objective : To determine whether oral Polypodium Leucotomos well tolerate study subject melasma . To determine whether treatment Polypodium Leucotomos improve health-related quality life .</brief_summary>
	<brief_title>Oral Polypodium Leucotomos Melasma</brief_title>
	<detailed_description>Polypodium Leucotomos fern , also know Calaguala use native northern Honduras treatment malignant tumor Used Spain Central America treatment psoriasis , atopic dermatitis repigmentation vitiligo . Oral Polypodium Leucotomos safe effective patient melasma .</detailed_description>
	<mesh_term>Melanosis</mesh_term>
	<criteria>Healthy female subject 1850 year age . Female subject epidermal melasma . Female subject childbearing potential must willing use acceptable form birth control duration study . Subjects Fitzpatrick skin type II , III , &amp; IV Subjects enrol trial 2 week washout period prior treatment melasma . Pregnant lactate Dermal Melasma Hormonal therapy less equal 4 week prior study Use photosensitize medication Simultaneous use form treatment melasma Subjects concurrently receive light therapy Subjects unwilling limit amount sun exposure Simultaneous ( past 30 day ) participation clinical research study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Melasma</keyword>
</DOC>